Showing results (271-280 of 344) with videos related to

Sort By:
Pageof 35
Annals of Hematology|March 28, 2021
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter studySalvatore Leotta, Uros Markovic, Maria Cristina Pirosa, et al.
European Journal of Haematology|September 25, 2023
Gaucher disease prevalence in 600 patients affected by monoclonal gammopathy of undetermined significanceGaetano Giuffrida, Uros Markovic, Annalisa Condorelli, et al.
The New England Journal of Medicine|September 4, 2014
Autologous transplantation and maintenance therapy in multiple myelomaAntonio Palumbo, Federica Cavallo, Francesca Gay, et al.
Blood|March 10, 2011
AIDA 0493 protocol for newly diagnosed acute promyelocytic leukemia: very long-term results and role of maintenanceGiuseppe Avvisati, Francesco Lo-Coco, Francesca Paola Paoloni, et al.
Annals of Hematology|October 25, 2018
Is re-challenge still an option as salvage therapy in multiple myeloma? The case of REal-life BOrtezomib re-Use as secoND treatment for relapsed patients exposed frontline to bortezomib-based therapies (the REBOUND Study)Pellegrino Musto, Vittorio Simeon, Nicola Cascavilla, et al.
American Journal of Hematology|October 10, 2012
Genome-wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profilesLaura Mosca, Pellegrino Musto, Katia Todoerti, et al.
Blood|July 20, 2002
MDR1 protein expression is an independent predictor of complete remission in newly diagnosed adult acute lymphoblastic leukemiaAgostino Tafuri, Chiara Gregorj, Maria T Petrucci, et al.
Leukemia|June 24, 2024
Early reappearance of intraclonal proliferative subpopulations in ibrutinib-resistant chronic lymphocytic leukemiaFederico Pozzo, Gabriela Forestieri, Filippo Vit, et al.
Cancer Medicine|November 6, 2020
The neutrophil to lymphocyte ratio (NLR) and the presence of large nodal mass are independent predictors of early response: A subanalysis of the prospective phase II PET-2-adapted HD0607 trialAlessandra Romano, Chiara Pavoni, Francesco Di Raimondo, et al.
Acta Oncologica (Stockholm, Sweden)|September 9, 2021
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational studyFabio Stagno, Massimo Breccia, Mario Annunziata, et al.
Pageof 35